Provincial drug programs will now cover Eliquis and Prolia
© Photo special to The Guardian.
A drug for those at risk for stroke and a treatment for osteoporosis have been added to the provincial formulary.
Effective Monday, Feb. 17, the two medications will be covered under provincial drug programs.
Apixaban (more commonly known as Eliquis) is used for the prevention of stroke and systemic embolism in patients with atrial fibrillation, in whom anticoagulation therapy is appropriate.
Denosumab (more commonly known as Prolia) is taken for the treatment of osteoporosis in post-menopausal women.
“The addition of these two new drugs builds upon the ongoing commitment of our government to improve the quality of health care in Prince Edward Island,” said Minister of Health and Wellness Doug Currie. “For many Islanders, their quality of life is tied to their medications, and the provision of these drugs will provide more options for Islanders.”
Both drugs will be added to the following drug programs: Children-In-Care Drug Program, Family Health Benefit Drug Program, Financial Assistance Drug Program, Nursing Home Drug Program, Seniors Drug Program and Catastrophic Drug Program. Patients must meet both the clinical and program criteria to be eligible for coverage.